Certara Announces Second Annual Certainty U.S. Event Announcement Certara 举办 Second Annual Certainty U.S. 活动 Certara’s premier client conference explores how in-silico methods and biosimulation at scale derisk every stage…Certara2025 年 4 月 22 日
How to Use Fix Tips for Better Clinical Data Issue Management Blog 如何利用修复技巧优化临床数据问题管理 2025 年 4 月 15 日 Prior to submission to any regulatory agency, standardized study data is evaluated using at…Certara2025 年 4 月 15 日
Revolutionizing Medical Writing: AI Accelerates Drug Development Efficiency [Chinese webinar] Webinar 重塑医学写作:人工智能加快药物开发效率 [中文网络研讨会] Certara2025 年 4 月 10 日
The Revolution of Metadata Standardization with Clinical Metadata Repository (CMDR) On-Demand Webinar 利用临床元数据存储库 (CMDR) 重塑元数据标准化 Solution Consultant, Software, APAC (Japan) Rico Fujita is a Software Solution Consultant in Japan, APAC.…Certara2025 年 3 月 27 日
Exploring Common CDISC ADaM Conformance Findings Blog Exploring Common CDISC ADaM Conformance Findings 2025 年 3 月 27 日 ADaM data are required by the FDA and PMDA and accepted by…Certara2025 年 3 月 27 日
Introducing the new Certara.com: Transforming drug development for good, together. 博客 Introducing the new Certara.com: Transforming drug development for good, together. 2025 年 3 月 26 日 We’re thrilled to introduce the launch of our revamped website and refreshed…Certara2025 年 3 月 26 日
Maximizing Clinical Efficiency: Simplifying SDTM Dataset workflow with the power of standardized metadata [APAC Webinar] On-Demand Webinar 破局临床效率瓶颈:标准化元数据驱动SDTM数据集一键生成【亚太地区网络研讨会】 Lorem ipsum dolor sit amet consectetur. Donec diam risus volutpat tempor. Massa accumsan aliquam nibh…Certara2025 年 3 月 11 日
Model-Informed Drug Development in the Age of AI On-Demand Webinar 人工智能时代的模型引导的药物开发 Lorem ipsum dolor sit amet consectetur. Donec diam risus volutpat tempor. Massa accumsan aliquam nibh…Certara2025 年 3 月 10 日
Certara Integral: The Master Data Repository Powering Efficient and Collaborative PK/PD Workflows Webinar Certara Integral:主数据库助力高效协作的 PK/PD 工作流程 Certara2025 年 3 月 5 日
Postmarketing Assessment of Antibody–Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach Publication Postmarketing Assessment of Antibody–Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach This study explores a model-based meta-analysis (MBMA) and a clinical utility index (CUI) approach to…Certara2025 年 3 月 4 日